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Osteopetrosis is a congenital clinical syndrome characterised by failure of osteoclasis resulting in impaired 
bone remodelling. The resultant bony defect 
leads to bone fragility (with a resultant propensity 
to fractures despite increased bone mass), 
haemopoietic insufficiency, nerve entrapment 
syndromes and growth impairment. Osteopetrosis 
was first described by a German radiologist, Albers-
Schonberg in 1904.1 It is a heterogeneous disorder 
describing a cluster of clinical entities sharing a 
common pathogenic nexus in the osteoclast.2 This 
rare condition is often missed; it presents with 
multiple fractures and osteosclerotic bones of 
no known cause and without any prior traumatic 
events. Three forms of the disease are diagnosed 
in infancy, childhood and adulthood.3 We hereby 
describe the first case from Eastern Africa of the 
adolescent-onset form of osteopetrosis.
Case Report 
A 23 year-old lady presented in Nairobi, Kenya 
for admission with a 2-week history of headaches, 
general malaise and body weakness. Over the 3 days 
prior to admission, she had gone blind and had to 
drop out of her college work in order to visit the 
hospital for care. Six month prior to presentation 
she had been seen elsewhere for episodes of severe 
temporal headaches associated with some visual 
disturbance and nausea/vomiting. The diagnosis 
was optic neuritis and she was put on methyl-
prednisolone for 6 months until her presentation 
with blindness. For the 4 months prior to admission, 
she noted increased weight; she also had a previous 
history of fractured tibia, fibula and humerus for 
which internal fixation had been done.
On examination, she was pyrexic and had 
obvious cushinoid features. Neurologically, she was 
fully awake with Glasgow Coma Scale (GCS) scale 
of 15/15. The only findings wree those of 
quadriparesis (motor power 3, all limbs) and the 
optic fundii being oedematous with raised obscuring 
everted margins and bilateral optic atrophy. She 
had suprapubic tenderness and epigastric guarding 
with marked tenderness and hepatosplenomegaly. 
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aBstract: Late-onset visual loss is a complication of nerve entrapment and increased intracranial pressure. We 
hereby describe the first case in Eastern Africa. A 23 year-old lady presented with sudden blindness, headaches 
and body weakness. She had previously had treatment for multiple unexplained fractures. Findings of optic nerve 
entrapment explained this blindness. This case highlights the need to have a high index of suspicion in cases of 
unexplained fractures with late-onset blindness.
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She had frontal bossing and nystagmus. During the 
physical examination she had a grand mal seizure.
Only limited investigations could be done due to 
the financial limitations of the family. The pertinent 
ones were as follows. The urine culture sensitivity 
parameters showing increased pus cells and 
white blood cells (WBC) at 20–40 /hpf; 48 hours 
incubation yielded a growth of Escherichia 
coli organisms sensitive to all quinolines. A 
full haemogram showed haemoglobin of 9.5 
gm and WBC count of 23 with a neutrophilic 
preponderance. The peripheral film showed a 
microcytic hypochromic picture. Liver function 
tests showed raised transaminases. Renal function 
tests, uric acid and thyroid function tests were all 
normal; however, the calcium levels were low at 1.8 
Mmol/L. Serial blood sugars remained elevated and 
were controlled on a sliding scale of insulin therapy 
tailored to a glycaemic level of 4–7 Mmol/L. The 
glycaemic excursions remained erratic throughout 
the admission period with sporadic high levels (26 
Mmol/L), but mainly an average of 16 Mmol/L 
as the highest peak. Glycated haemoglobin was 
elevated at 12%. Both C reactive protein and 
D-Dimers were elevated (15 and 23 respectively), 
but there were unreactive serum HIV antigens. 
A previous antibody test had been inconclusive. 
The electroencephalogram (EEG) reading was 
unremarkable. 
A lumbar puncture was done under aseptic 
condition at lumbar levels 3/4 regions with one 
pass. The cerebrospinal fluid (CSF) was under 
pressure (240 mm of water) and appeared clear on 
observation. The CSF sample was sent for cytology, 
biochemistry and microbiology testing. The only 
significant finding was an increased glucose level of 
14 Mmol/L. 
Blood lipids were markedly elevated (both 
 
Figure 1: Computed tomography scans of head showing gross thickening and sclerosis of cranial vault and skull base. 
Also noted is the internal acoustic meatal narrowing.
 
Figure 2: (A) Thickening of base of skull causing narrowing of optic canal (arrow), and (B) Compression of the optic 
nerve, resulting in bulbous dilatation of the retrobulbar optic nerve sheath and posterior scleral flattening (arrow).
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total and low density lipoprotein cholesterol and 
triglyceride levels). Blood cultures were done as part 
of the septic screening and no growth was obtained. 
Anti-nuclear antibodies and factors, hepatitis A, B, 
C, and tuberculosis polymerase chain reaction tests 
were all negative.
The chest radiograph showed generalised 
osteoporosis with a visible humerus fracture 
and metallic implant in situ. Generalised bone 
osteosclerosis was noted. The abdominal 
ultrasound was normal with the exception of 
hepatosplenomegaly. No other abnormalities were 
seen. An enhanced computed tomography (CT) 
scan of the head  showed gross hyperdensity of the 
cranial vault and the base of skull consistent with 
osteopetrosis [Figure 1]. Also visible was a narrowing 
of the optic canals and internal auditory meatus. 
A CT scan of the orbits showed bilateral dense 
sclerosis of the bones consistent with osteopetrosis 
with reduced optic canal circumference (4.4 mm x 
3.7 mm right and 4.0 mm x 3.5 mm left) [Figure 2]. 
Magnetic resonance (MR) imaging showed multiple 
subacute infarcts with thickening of the orbital 
bones at the optic canal causing narrowing of the 
optic nerve [Figure 3]. The optic nerve was tortuous 
causing the flattening of sclera posteriorly as well 
as bilateral bulbous dilatation of the retrobulbar 
optic nerve sheath. This had led to bilateral optic 
canal stenosis causing optic nerve atrophy. An MR 
angiography showed bilateral segmental narrowing 
of the distal vertebral arteries and proximal basilar 
artery and, to a milder extent, of both internal 
carotid arteries at the level of the siphon [Figure 4]. 
Focal narrowing of proximal right middle cerebral 
artery was also observed.
This was a clear case of late-onset osteopetrosis 
with the long term steroid use associated conditions 
of Cushing’s disease, diabetes, dyslipidaemia, 
peptic ulcer syndrome  and osteoporosis. The 
osteopetrosis had caused anaemia, internal carotid 
compression and narrowing of vertebral arteries, 
cerebral infarcts, multiple fractures, and bilateral 
optic canal stenosis causing bilateral optic atrophy.
The patient was treated with sodium valproate 
to prevent seizures, enteric-coated aspirin with 
clopidegrol, rosuvastatin, insulin, iron supplement, 
ciprofloxacin, sertralline, metformin, glimepiride, 
calcitriol supplement, oxybral, vitamin D, gamma 
interferon, erythropoietin, diclofenac and 
physiotherapy. Calcitriol use is controversial, but 
in this index case it was also given for the assumed 
short-term benefit. The patient made a moderate 
improvement and was able to be ambulated with 
minimal support and could feed herself as well as 
 
Figure 3: (A & B) Axial FLAIR images and (C & D) diffusion weighted images showing multiple subacute infarcts. Skull 
thickening is also noted in the FLAIR sequences (A & B ).
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undertake basic living activities unaided. 
An intraventricular catheter was placed showing 
an intracranial pressure of 32 mmHg. Via the same 
catheter, the cerebral spinal fluid was drained until 
the levels reached 8 mmHg. The catheter was left in 
situ as further surgical options were being discussed 
with the patient’s family. The visual acuity remained 
poor (with only finger movements visible) and 
she thus became very depressed, as she had to 
discontinue college work and start learning Braille. 
On antidepressants and psychosocial counselling 
support this depressive component of her condition 
improved well.
Unfortunately, the patient’s family was unable 
to pay for the much needed definitive optic canal 
decompression and cranial vault expansion surgery. 
The hospital did not have the ability at the time to 
offer complimentary care. Hence a referral to the 
public hospital system was the only option. A surgical 
widening of the optic canal and decompression 
of the vertebral arteries was considered to be too 
dangerous in a public hospital due to their lack 
of equipment and level of postoperative care. 
Consequently, the consensus was to  abandon the 
option of surgical intervention and refer the patient 
to a public hospital for conservative and supportive 
management.
 
Figure 4: (A & B) Magnetic resonance angiography source and reformatted images showing segmental narrowing of 
distal verterbral arteries (B, arrows) and proximal basilar arteries and to a milder extent of both internal carotid arteries 
at the level of the siphon. Focal narrowing of the  proximal right middle cerebral artery is also noted.
Discussion
In 1999, Baron reviewed what is known in cell 
biology of bone remodelling4 and the process of 
bone remodeling was further elucidated by Plow 
et al.5 Osteoblasts are of fibroblastic origin whose 
function is to synthesise bone matrix in new 
osteocytes. In contrast, osteoclasts are derived from 
macrophage/monocyte lineage and they function 
in solubilisation of bone mineral causing bone 
resorption.
Bone modelling is the process of changing bone 
shape and is prominent in childhood causing growth. 
Remodelling, on the other hand, is the degradation 
of bone tissue from existing bony structures and 
replacing these with newly synthesised bony cells. 
Osteopetrosis is the failure of modelling leading to 
improper growth and overgrowth of bony surfaces. 
This causes constriction of other structures, which 
leads to the myriad of conditions that constitute the 
disease process. The primary underlying defect in 
osteopetrosis is failure of the osteoclasts to reabsorb 
bone. The exact molecular or genetic defect and site 
of these mutations are largely unknown.
Osteopetrosis is thought to be autosomal 
dominant in adult-onset disease, but recessive 
in both infantile- and intermediate-onset. The 
condition is often diagnosed incidentally (usually 
before age 1 year) due to the effects on other tissues 
affected by the bone modeling limitations of the 
disease. 
Overall, the global incidence is unknown 
because no epidemiological studies have been 
conducted; however, one estimate suggested 1 case 
in 100,000–500,000 in the population.6 Untreated, 
the infantile form results in death by the first 
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decade of life due to severe anaemia, resultant 
cardiac failure, bleeding and/or severe sepsis. In its 
adult form, osteopetrosis is usually a milder form of 
disease with good prognosis.
From the history, our patient had the childhood 
form with the consequences of bony defects: 
neuropathies due to nerve entrapment (in our 
case optic canal stenosis/atrophy/blindness), 
frontal bossing and paraparesis; haemopoetic 
consequences (anaemia, hepatosplenomegaly), and 
infections (in our case urinary tract infection and 
septicaemia).
Medical care with high dose calcitriol (vitamin 
D) helps by stimulating dormant osteoclasts and 
thus stimulating bone resorption.7 Although 
controversial, this treatment usually produces 
a dramatic result which unfortunately is not 
sustained after the therapy ceases. Gamma 
interferon produces long-term benefits especially in 
combination with calcitriol. Erythropoietin corrects 
anaemia, and corticosteroids have been used to 
correct the anaemia and stimulate bone resorption. 
In our index case, the patient was put on steroids 
for too long (6 months) prior to our seeing her and 
she had thus developed steroid therapy side effects.
Definitive treatment also involves novel 
approaches such as bone marrow transplants, 
although these are unavailable in the Eastern 
Africa region. In several case series where this has 
been possible, there has been proven success in 
altering the course of the disease; however, visual 
improvement rarely occurs.8  
Conclusion
In osteopetrosis, surgical treatment is often 
necessary for the constellation of problems related 
to bony defects,9 usually to manage fractures. Prior 
to presentation, our patient had had four surgeries 
for internal fixation of fractures. There is a definite 
benefit from intracranial surgery to decompress soft 
tissue (vessels and nerve) entrapment syndromes. 
Such definitive optic canal decompression and 
cranial vault expansion surgery would have assisted 
this case. 
Unfortunately, a surgical widening of the optic 
canal and decompressing the vertebral arteries was 
considered to be too dangerous in a public hospital 
with resource constraints, yet the parents could not 
afford the care at the private facility where she was 
admitted. We were unwilling to refer the patient for 
surgery in a public hospital. Although the facilities 
are there, the surgical supplies, equipment and, 
more importantly, postsurgical care were wanting 
in a public facility. We thus had to defer surgery in 
the private hospital and refer her to a public health 
facility for conservative care.
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